NCT00445419View on ClinicalTrials.gov

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

June 30, 2008

Conditions

Chronic Hepatitis C

Interventions

BIOLOGICAL

PEV2A PEV2B

Trial Locations (1)

1011

Vaccine and Immunotherapy Center, CHUV, Lausanne

Sponsors

Lead Sponsor

Pevion Biotech Ltd

All Listed Sponsors

lead

Pevion Biotech Ltd

INDUSTRY

NCT00445419 - Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides | Biotech Hunter | Biotech Hunter